NMD Pharma Reports Positive Top-Line Data from a Phase I/IIa

NMD Pharma Reports Positive Top-Line Data from a Phase I/IIa Clinical Trial of NMD670 in Patients with Myasthenia Gravis

NMD Pharma Reports Positive Top-Line Data from a Phase I/IIa Clinical Trial of NMD670 in Patients with Myasthenia Gravis
dkoding.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dkoding.in Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , United States , Netherlands , Denmark , Geert Jan Groeneveld , Gravis Scorein , Lundbeckfonden Biocapital , Thomas Holm Pedersen , Drug Administration , International Clinical Trials Registry , Centre For Human Drug Research , European Union , Roche Venture Fund , Novo Holdings , Consilium Strategic Communications , Aarhus University , Reports Positive Top Line Data , Clinical Trial , Quantitative Myasthenia Gravis Scorein , Quantitative Myasthenia Gravis Score , Human Drug Research , Chief Scientific Officer , Chief Medical Officer , Principal Investigator , Holm Pedersen , Chief Executive Officer , Jane Elliott , Ashley Tapp , Lindsey Neville , Myasthenia Gravis , Human Drug ,